Literature DB >> 22038135

[Diagnosis and differential diagnosis of cervical adenocarcinoma].

T Löning1, L Riethdorf, M Köbel.   

Abstract

This overview summarizes pathogenetic and practical aspects of (sub-)classification of cervical glandular (pre-)neoplasias and, inter alia, calls into question the usefulness of grading. In the context of the differential diagnosis of benign "imitations", the phenotypic variability of glandular precancerous lesions and carcinomas is described as well as the use of special tests to distinguish them. With regard to carcinomas, the differential diagnosis of well-differentiated neoplasias is addressed including "minimal deviation" adenocarcinoma (MDA, malignant adenoma), carcinomas with endometrioid or villoglandular morphology, and mesonephric hyper- and neoplasias. Furthermore, knowledge of HPV-negative glandular (pre-)neoplasias is covered including "gastric-type" adenocarcinomas and diagnostic algorithms for discriminating between primary and secondary cervical adenocarcinomas. Finally, comments are offered on the difficulties in recognizing early invasive adenocarcinomas, especially also the pitfalls inherent in determining the depth of invasion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038135     DOI: 10.1007/s00292-011-1481-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  26 in total

1.  A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.

Authors:  Christina S Kong; Andrew H Beck; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2010-07       Impact factor: 6.394

2.  Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?

Authors:  J J Park; D Sun; B J Quade; C Flynn; E E Sheets; A Yang; F McKeon; C P Crum
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

3.  p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix.

Authors:  Lars-Christian Horn; Kristin Lindner; Grit Szepankiewicz; Jeanett Edelmann; Bettina Hentschel; Andrea Tannapfel; Karl Bilek; Uwe-Gerd Liebert; Cristine E Richter; Jens Einenkel; Cornelia Leo
Journal:  Int J Gynecol Pathol       Date:  2006-04       Impact factor: 2.762

Review 4.  Adenocarcinoma: a unique cervical cancer.

Authors:  Lilian T Gien; Marie-Claude Beauchemin; Gillian Thomas
Journal:  Gynecol Oncol       Date:  2009-10-31       Impact factor: 5.482

5.  Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.

Authors:  Yasuki Kusanagi; Atsumi Kojima; Yoshiki Mikami; Takako Kiyokawa; Tamotsu Sudo; Satoshi Yamaguchi; Ryuichiro Nishimura
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

6.  Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival.

Authors:  Martin C Chang; Nicole S Nevadunsky; Akila N Viswanathan; Christopher P Crum; Colleen M Feltmate
Journal:  Int J Gynecol Pathol       Date:  2010-01       Impact factor: 2.762

7.  Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist?

Authors:  N S Goldstein; E Ahmad; M Hussain; R C Hankin; N Perez-Reyes
Journal:  Am J Clin Pathol       Date:  1998-08       Impact factor: 2.493

8.  Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Authors:  Anna Yemelyanova; Hongxiu Ji; Ie-Ming Shih; Tian-Li Wang; Lee-Shu-Fune Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

9.  Symposium part 4: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ?: Counterpoint.

Authors:  Kenneth R Lee
Journal:  Int J Gynecol Pathol       Date:  2003-01       Impact factor: 2.762

10.  Inter-laboratory validation of PCR-based HPV detection in pathology specimens.

Authors:  Iver Petersen; Christiane Schewe; Karsten Schlüns; Manfred Dietel; Norbert Speich; Christoph Schmitt; Magdolna Bollmann; Karl Sotlar; Burkhard Bültmann; Maria T Dours-Zimmermann; Barbara Padberg; Dieter R Zimmermann
Journal:  Virchows Arch       Date:  2007-07-10       Impact factor: 4.535

View more
  1 in total

1.  Progression or Regression? - Strengths and Weaknesses of the New Munich Nomenclature III for Cervix Cytology.

Authors:  Z Hilal; C Tempfer; S Schiermeier; J Reinecke; C Ruppenkamp; Z Hilal
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.